Olanzapine - Relapse prevention following mania

Journal of Psychopharmacology

Volumn 20, Issue 2 SUPPL., 2006, Pages 31-38

  Dando, Simon ^a   Tohen, Mauricio ^a,b  

^a ELI LILLY AND COMPANY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Antipsychotic; Atypical; Bipolar; Efficacy; Lithium; Maintenance; Mania; Olanzapine; Tolerability; Valproate

Indexed keywords

LITHIUM; MOOD STABILIZER; OLANZAPINE; PLACEBO; VALPROATE SEMISODIUM; VALPROIC ACID;

AKATHISIA; ANXIETY DISORDER; APPETITE DISORDER; ASTHENIA; BIPOLAR I DISORDER; CLINICAL TRIAL; CONFERENCE PAPER; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; DYSKINESIA; EXTRAPYRAMIDAL SYMPTOM; FATIGUE; HAMILTON SCALE; HUMAN; HYPERSOMNIA; INSOMNIA; MAINTENANCE THERAPY; MANIA; META ANALYSIS; METABOLIC DISORDER; NAUSEA; NERVOUSNESS; PAIN; PARKINSONISM; PRIORITY JOURNAL; RATING SCALE; RECURRENT DISEASE; RELAPSE; SCORING SYSTEM; SIDE EFFECT; SOMNOLENCE; SYSTEMATIC REVIEW; WEIGHT GAIN; WEIGHT REDUCTION; XEROSTOMIA;

EID: 33645098999     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/1359786806063076     Document Type: Conference Paper

References (11)

1. Baldessarini R, Tondo L (2000) Does lithium treatment still work? Evidence of stable response over three decades. Arch Gen Psychiatry 57: 187-190
2. Geddes J, Burgess S, Hawton K, Jamison K, Goodwin G (2004) Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomised controlled trials. Am J Psychiatry 161: 217-222; correction 161: 1517
3. Goldberg J, Harrow M, Grossman L (1995) Recurrent affective syndromes in bipolar and unipolar mood disorders at follow up. Br J Psychiatry 166: 382-385
4. Hirschfeld R, Baker J, Wozniack P, Tracy K, Sommerville K (2003) The safety and early efficacy of oral-loaded divalproex versus standardtitration divalproex, lithium, olanzapine, and placebo in the treatment of acute mania associated with bipolar disorder. J Clin Psychiatry 64(7): 841-846
5. Tohen M, Waternaux C, Tsuang M (1990) Outcome in mania: a 4-year prospective follow-up of 75 patients utilizing survival analysis. Arch Gen Psychiatry 47: 1106-1111
6. Tohen M, Zarate C, Hennen J, Khalasa H, Strakowski S, Gebre-Medhin P, Salvatore P, Baidessarini R (2003a) The McLean-Harvard first episode mania study: prediction of recovery and first recurrence. Am J Psychiatry 160: 2099-2107
7. Tohen M, Calabrese J, Sachs G, Banov M, Detke H, Risser R, Baker R, Chou J, Bowden C (2006) A randomised, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute olanzapine treatment. Am J Psychiatry 163(2): 247-256
8. Tohen M, Hennen J, Zarate C, Baldessarini R, Strakowski S, Stoll A, Faedda G, Suppes T, Gebre-Medhin P, Cohen B (2000) Two-year syndromal and functional recovery in 219 cases of first-episode major affective disorder with psychotic features. Am J Psychiatry 157: 220-228
9. Tohen M, Ketter T, Zarate C, Suppes T, Frye M, Altshuler L, Zajecka J, Schuh L, Risser R, Brown E, Baker R (2003b) Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study. Am J Psychiatry 160: 1263-1271
10. Tohen M, Chengappa K, Suppes T, Baker R, Zarate C, Bowden C, Sachs G, Kupfer D, Ghaemi S, Feldman P, Risser R, Evans A, Calabrese J (2004) Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone. Br J Psychiatry 184: 337-345
11. Tohen M, Greil W, Calabrese J, Sachs G, Yatham L, Oerlinghausen B, Koukopoulos A, Cassano G, Grunze H, Licht R, Dell'Osso L, Evans A, Risser R (2005) Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomised double-blind, controlled clinical trial. Am J Psychiatry 162: 1281-1290